Consensus Exelon Corporation

Equities

EXC

US30161N1019

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
37.55 USD +2.37% Intraday chart for Exelon Corporation +2.93% +4.60%

Evolution of the average Target Price on Exelon Corporation

Price target over the last 5 years

History of analyst recommendation changes

97a030.xX2X2NO9khnBFYO78RgxdsPkH871vZVwJKOjW3atImU.ii3uipbb6GC1IbXPwUFGToGddYqz2s1GVfbLLgfiaSq1JOO2n4-kSKZCtw~385b3962d3e41d2c0c078f47194a05ab
Barclays Adjusts Price Target on Exelon to $39 From $36, Maintains Overweight Rating MT
Wells Fargo Cuts Price Target on Exelon to $39 From $41, Maintains Equalweight Rating MT
Exelon beats Q4 profit estimates on higher electricity rates RE
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up MT
Barclays Cuts Price Target on Exelon to $36 From $38, Maintains Overweight Rating MT
BofA Adjusts Price Target on Exelon to $36 From $38, Keeps Neutral Rating MT
In wait-and-see mode Our Logo
Mizuho Securities Upgrades Exelon to Buy From Neutral, Raises Price Target to $39 From $36 MT
ANALYST RECOMMENDATIONS : Apple, Block, Palo Alto, Wise, Workday... Our Logo
Seaport Downgrades Exelon to Neutral From Buy MT
UBS Downgrades Exelon to Neutral From Buy, Adjusts Price Target to $37 From $47 MT
RBC Cuts Price Target on Exelon to $38 From $45 Amid Illinois Grid Plan Rejection, Keeps Sector Perform Rating MT
Exelon 2025 EPS Forecast Lowered by Morgan Stanley Following Illinois Regulator's Rate Case Decision MT
Mizuho Adjusts Exelon's Price Target to $36 From $40, Keeps Neutral Rating MT
JPMorgan Downgrades Exelon to Neutral From Overweight, Cuts Price Target to $41 From $46 MT
Morgan Stanley Downgrades Exelon to Equalweight From Overweight, Cuts Price Target to $38 From $45 Amid 'Unfavorable' Illinois Rate Case Decision MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce... Our Logo
Evercore ISI Downgrades Exelon to In Line From Outperform MT
Guggenheim Downgrades Exelon to Neutral From Buy, Cuts Price Target to $40 From $44 MT
Ameren Downgraded by KeyBanc to Sector Weight From Overweight Amid Disappointment Over Illinois Rate Case Decision MT
ANALYST RECOMMENDATIONS : Best Buy, Glencore, Lowe's, Nvidia, Clorox... Our Logo
Morgan Stanley Raises Price Target on Exelon to $43 From $42, Maintains Overweight Rating MT
Mizuho Securities Downgrades Exelon to Neutral From Buy, Cuts Price Target to $40 From $45 MT
ANALYST RECOMMENDATIONS : Ashtead, Crowdstrike, Hershey, Ulta Beaty, Zoom... Our Logo
Morgan Stanley Adjusts Price Target on Exelon to $42 From $45, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
37.55 USD
Average target price
38.57 USD
Spread / Average Target
+2.72%
High Price Target
41.12 USD
Spread / Highest target
+9.51%
Low Price Target
36 USD
Spread / Lowest Target
-4.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Exelon Corporation

Barclays
Wells Fargo Securities
BofA Securities
Mizuho Securities
Seaport Global Securities
UBS
RBC Capital Markets
JPMorgan Chase
Morgan Stanley
Evercore ISI
Guggenheim
BMO Capital
Credit Suisse
KeyBanc Capital Markets
Goldman Sachs
Argus
Scotiabank
Vertical Research
Spin-Off Research
Wolfe Research
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. EXC Stock
  4. Consensus Exelon Corporation